All lobbying filings

Innovative Federal Strategies, LLC

Innovative Federal Strategies, LLC filed a Q2 report for Cerus Corporation on July 20, 2026, reporting $40,000 in lobbying income.

Lobbying for Cerus Corporation

As filed: INNOVATIVE FEDERAL STRATEGIES, LLC for CERUS CORPORATION.

All filings by Innovative Federal Strategies, LLC · Everything Cerus Corporation has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Budget/Appropriations

H.R.9495/S.____ Department of Defense Appropriations Bill, 2027, Title VI, all provisions related to blood safety. H.R.9260/S.____ Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027 - Title II, all provisions related to blood safety.

Defense

H.R.8800/S.____ National Defense Authorization Act, 2027, Title XIV, all provisions related to blood safety.

Health Issues

Contacted officials regarding the Red Blood Cell Clinical Trial Program and blood safety issues.

Bills named in this filing 3

H.R. 9495
Department of Defense Appropriations Act, 2027
H.R. 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
H.R. 8800
National Defense Authorization Act for Fiscal Year 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.